<- Go Home
Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Market Cap
$47.9M
Volume
2.9K
Cash and Equivalents
N/A
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$154.2K
Profit Margin
100.00%
52 Week High
$10.04
52 Week Low
$7.11
Dividend
N/A
Price / Book Value
1.47
Price / Earnings
28.37
Price / Tangible Book Value
1.47
Enterprise Value
$49.5M
Enterprise Value / EBITDA
N/A
Operating Income
-$722.4K
Return on Equity
5.35%
Return on Assets
-1.39
Cash and Short Term Investments
N/A
Debt
$1.6M
Equity
$32.7M
Revenue
$154.2K
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium